Abstract
Background
The pharmaceutical industry promotes prescribing through the cultivation of key opinion leaders. Advanced practice nurses (APNs) are a growing and influential group of prescribers across generalist and specialty practice. Public reporting of industry payments to APNs allows for exploration of their influence within practice settings.
Objective
To understand the characteristics of APNs with top industry payments including their positions of influence and other payment recipients at the same address.
Design and Setting
Cross-sectional study of US national Open Payments reports of industry payments made between January 1, 2021, and December 31, 2021.
Participants
APNs who received > $50,000 USD in industry payments for speaking, consulting, and honoraria (“personal fees”).
Measures
Description of top APN recipients’ practice setting type, clinical specialty, presence of other payment recipients, value of payments attributed to the same address, and top manufacturers and therapeutic categories associated with payments to top APN recipients. Structured content analysis of public-facing websites for evidence of APNs’ clinical, research, and teaching leadership.
Results
A total of 99 APNs received > $50,000 USD in aggregate personal fees and a median $74,080 USD (IQR $57,303–101,702) in aggregate payments. They shared a practice setting with a median of 1 (IQR 0–5) physician and 0 (IQR 0–3) other APN payment recipients and were often the only (39%, 42/109) or the dominant (45%, 30/67) payment recipient in their practice setting. In total, 36% held clinical leadership positions, 25% led scientific research, and 18% had university appointments. Forty-two percent (37/88) owned a clinical practice, including cosmetic clinics (51%, 19/37) and mental/behavioral health clinics (24%, 9/37).
Conclusions
Top APN payment recipients attracted high-value payments in practice settings and specialities associated with high-cost drug development; however, there may be little oversight of APNs’ industry relationships. Policy development related to industry relationships must be inclusive of and responsive to the activities of interprofessional providers.
Similar content being viewed by others
Data Availability
All data pertaining to payment records are publicly available for download from the Center for Medicare and Medicaid Services Open Payments website at: https://openpaymentsdata.cms.gov and NPPES https://download.cms.gov/nppes/NPI_Files.html
References
Sismondo S. Ghost-Managed Medicine: Big Pharma’s Invisible Hands. Manchester: Mattering Press; 2018.
Steinman MA, Bero LA, Chren M-M, Landefeld CS. Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Ann Intern Med. 2006;145:284–293. https://doi.org/10.7326/0003-4819-145-4-200608150-00008
Wright K, Meyers DE, Chisamore TM, et al. Industry relationships with medical oncologists: Who are the high-payment physicians? JCO Oncol Pract. 2022;18:e1164–e1169. https://doi.org/10.1200/OP.21.00756.
Rep. Walden G. H.R.6 - SUPPORT for Patients and Communities Act. 115–271 2018, 2017.
Karanges EA, Grundy Q, Bero L. Understanding the nature and extent of pharmaceutical industry payments to nonphysician clinicians. JAMA Intern Med. 2019;179:1430–1432. https://doi.org/10.1001/jamainternmed.2019.1371.
NP Fact Sheet. Am. Assoc. Nurse Pract. Available at: https://www.aanp.org/about/all-about-nps/np-fact-sheet. Accessed March 7, 2022.
Zhang AD, Anderson TS. Comparison of industry payments to physicians and advanced practice clinicians. JAMA. 2022;328:2452. https://doi.org/10.1001/jama.2022.20794.
Singh A, Hyman MJ, Modi PK. Evaluation of industry payments to US advanced practice clinicians in 2021. JAMA Netw Open. 2022;5:e2242869. https://doi.org/10.1001/jamanetworkopen.2022.42869.
Sismondo S, Chloubova Z. “You’re not just a paid monkey reading slides”: How key opinion leaders explain and justify their work. BioSocieties. 2015;11:199–219. https://doi.org/10.1057/biosoc.2015.32.
Klein T, Graves J. The scope of inclusion of academic conflict of interest policies. J Acad Ethics. 2018;16:103–116. https://doi.org/10.1007/s10805-017-9298-6.
Centers for Medicare & Medicaid Services (CMS). Open payments public use files: Methodology overview & data dictionary. Baltimore, MD; 2022. Available at: https://www.cms.gov/openpayments/downloads/openpaymentsdatadictionary.pdf. Accessed February 10, 2022.
Prener C. postmastr: Tidy Tools for Standardizing and Parsing Street Addresses. 2022. Available at: https://github.com/slu-openGIS/postmastr. Accessed May 26, 2023.
R Core Team. R: A language and environment for statistical computing. Vienna, Australia: R Foundation for Statistical Computing; 2021. Available at: https://www.R-project.org/. Accessed February 24, 2022.
Given LM, Saumure K. Data Saturation. Sage Encycl Qual Res Methods. Los Angeles, CA: Sage publications; 2008:195–196.
Internet Archive. Wayback Machine. Available at: https://archive.org/web/. Accessed May 26, 2023.
Winn AN, Mitchell AP, Fergestrom N, Neuner JM, Trogdon JG. The role of physician professional networks in physicians’ receipt of pharmaceutical and medical device industries’ payments. J Gen Intern Med. 2021;36:1858–1866. https://doi.org/10.1007/s11606-021-06802-9.
Inoue K, Blumenthal DM, Elashoff D, Tsugawa Y. Association between physician characteristics and payments from industry in 2015–2017: observational study. BMJ Open. 2019;9:e031010. https://doi.org/10.1136/bmjopen-2019-031010.
The IQVIA Institute. The global use of medicines 2023. Durham, NC: IQVIA; 2023. Available at: https://www.iqvia.com/insights/the-iqvia-institute/reports/the-global-use-of-medicines-2023. Accessed October 6, 2023.
DeJong C, Aguilar T, Tseng C, Lin GA, Boscardin W, Dudley R. Pharmaceutical industry–sponsored meals and physician prescribing patterns for medicare beneficiaries. JAMA Intern Med. 2016;176:1114–1122. https://doi.org/10.1001/jamainternmed.2016.2765.
Khan R, Nugent CM, Scaffidi MA, Gimpaya N, Grover SC. Association of biologic prescribing for inflammatory bowel disease with industry payments to physicians. JAMA Intern Med. 2019;179:1424–1425. https://doi.org/10.1001/jamainternmed.2019.0999.
Greenway T, Ross JS. US drug marketing: how does promotion correspond with health value? BMJ. 2017;357:j1855. https://doi.org/10.1136/bmj.j1855.
Grundy Q. Infiltrating healthcare: How marketing works underground to influence nurses. Baltimore, MD; Johns Hopkins University Press; 2018.
Funding
This work was supported by the Greenwall Foundation Making a Difference Grant.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
The University of Toronto Research Ethics Board approved the study (#42961); however, the data reported in this paper was publicly available and did not involve the recruitment or participation of human subjects.
Conflict of Interest
QG, FH, DH, CB, EL, and LB declare no conflicts of interest. EGC has served as a paid expert witness for the Arizona Attorney General’s Office on a legal case related to conflicts of interest in medicine.
Disclaimer
The Greenwall Foundation had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Grundy, Q., Held, F., Hart, D. et al. Characteristics of Advanced Practice Nurses Receiving Top Industry Payments and Their Practice Settings: a Cross-sectional Study. J GEN INTERN MED 39, 1142–1148 (2024). https://doi.org/10.1007/s11606-023-08508-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-023-08508-6